Interestingly, EPHA4 expression was significantly higher in the highly aggressive basal-like breast cancer subtypes compared to luminal A, luminal B and Her-2 enriched subtypes (P < 0.00001) (Fig. 7A). The gene discussed is EPHA4; the disease is breast carcinoma.